158 related articles for article (PubMed ID: 20465394)
1. Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.
Al-Swiahb JN; Chen CH; Chuang HC; Fang FM; Tasi HT; Chien CY
Future Oncol; 2010 May; 6(5):837-50. PubMed ID: 20465394
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation.
Chen CH; Chuang HC; Huang CC; Fang FM; Huang HY; Tsai HT; Su LJ; Shiu LY; Leu S; Chien CY
Am J Pathol; 2013 Feb; 182(2):516-28. PubMed ID: 23219753
[TBL] [Abstract][Full Text] [Related]
3. Distinctive clinical and microscopic features of squamous cell carcinoma of oral cavity and lip.
Batista AC; Costa NL; Oton-Leite AF; Mendonça EF; Alencar Rde C; Silva TA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e74-9. PubMed ID: 20219590
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of oral cavity squamous cell carcinoma.
Kupferman ME; Myers JN
Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
[TBL] [Abstract][Full Text] [Related]
5. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
Kang CJ; Lin CY; Wang HM; Fan KH; Ng SH; Lee LY; Chen IH; Huang SF; Liao CT; Yen TC
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e223-30. PubMed ID: 21640500
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinomas of the oral cavity.
Cernea C; Montenegro F; Castro I; Cordeiro A; Gayotto L; Ferraz A; de Carlucci D
Am J Surg; 1997 Nov; 174(5):548-51. PubMed ID: 9374235
[TBL] [Abstract][Full Text] [Related]
7. Oral cavity squamous cell carcinoma in never smokers: analysis of clinicopathologic characteristics and survival.
Durr ML; Li D; Wang SJ
Am J Otolaryngol; 2013; 34(5):388-93. PubMed ID: 23540889
[TBL] [Abstract][Full Text] [Related]
8. The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity.
Shrime MG; Gullane PJ; Dawson L; Kim J; Gilbert RW; Irish JC; Brown DH; Goldstein DP
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):225-8. PubMed ID: 20231637
[TBL] [Abstract][Full Text] [Related]
9. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
10. Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma.
Hanna GJ; Woo SB; Li YY; Barletta JA; Hammerman PS; Lorch JH
Int J Oral Maxillofac Surg; 2018 May; 47(5):568-577. PubMed ID: 28969885
[TBL] [Abstract][Full Text] [Related]
11. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.
Scully C; Bagan J
Oral Dis; 2009 Sep; 15(6):388-99. PubMed ID: 19371401
[TBL] [Abstract][Full Text] [Related]
12. Oral cancer.
Kademani D
Mayo Clin Proc; 2007 Jul; 82(7):878-87. PubMed ID: 17605971
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma: new insights.
Jordan RC; Daley T
J Can Dent Assoc; 1997; 63(7):517-8, 521-5. PubMed ID: 9264211
[TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma of the oral cavity: clinical and pathological aspects.
Fronie A; Bunget A; Afrem E; Preoţescu LL; Corlan Puşcu D; Streba L; Mogoantă L; Dumitrescu D
Rom J Morphol Embryol; 2013; 54(2):343-8. PubMed ID: 23771079
[TBL] [Abstract][Full Text] [Related]
15. Molecular aspects of oral cancer.
Nagler RM
Anticancer Res; 2002; 22(5):2977-80. PubMed ID: 12530028
[TBL] [Abstract][Full Text] [Related]
16. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes of First Nations patients with oral cavity squamous cell carcinoma (Poliquin 2014).
Erickson B; Biron VL; Zhang H; Seikaly H; Côté DW
J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):4. PubMed ID: 25645260
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion.
Chen CH; Su CY; Chien CY; Huang CC; Chuang HC; Fang FM; Huang HY; Chen CM; Chiou SJ
Br J Cancer; 2008 Nov; 99(9):1453-61. PubMed ID: 18841160
[TBL] [Abstract][Full Text] [Related]
19. Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review.
Biolchini F; Pollastri G; Figurelli S; Chiarini L
Minerva Stomatol; 2005; 54(7-8):405-14. PubMed ID: 16210999
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations in oral cavity carcinoma.
Ragos V; S Mastronikolis N; Tsiambas E; Baliou E; N Mastronikolis S; Tsoukalas N; E Patsouri E; P Fotiades P
J BUON; 2018; 23(6):1569-1572. PubMed ID: 30610778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
